• 1
    Melegari M, Scaglioni PP, Wands JR. Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J Virol 1998; 72: 173743.
  • 2
    Marusawa H, Matsuzawa S, Welsh K, Zou H, Armstrong R, Tamm I, et al. HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J 2003; 22: 272940.
  • 3
    Minczuk M, Mroczek S, Pawlak SD, Stepien PP. Human ATP-dependent RNA/DNA helicase hSuv3p interacts with the cofactor of survivin HBXIP. FEBS J 2005; 272: 500819.
  • 4
    Fujii R, Zhu C, Wen Y, Marusawa H, Bailly-Maitre B, Matsuzawa S, et al. HBXIP, cellular target of hepatitis B virus oncoprotein, is a regulator of centrosome dynamics and cytokinesis. Cancer Res 2006; 66: 9099107.
  • 5
    Zhang X, Ma H, Ye L, Dong N, Shi Z, Sha L, et al. Effect of hepatitis B X interacting protein on apoptosis induced by hepatitis B virus X protein. Chin J Biochem Mol Biol 2005; 21: 4037.
  • 6
    Wang F, Sha L, Zhang W, Wu L, Qiao L, Li N, et al. Involvement of hepatitis B X-interacting protein (HBXIP) in proliferation regulation of cells. Acta Pharmacol Sin 2007; 28: 4318.
  • 7
    Wang F, Wu L, Qiao L, Ye L, Zhang X. Promotion of cell proliferation via regulating cell cycle induced by HBXIP. Chin J Biochem Mol Biol 2007; 23: 48791. Chinese.
  • 8
    Wang F, Sha L, Qiao L, Wu L, Zhang X, Ye L. Promotion of transcriptional activity of NF-κB mediated by HBXIP in hepatoma cells. Prog Biochem Biophys 2007; 34: 1197201. Chinese.
  • 9
    Zhang X, Dong N, Zhang H, You J, Wang H, Ye L. Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells. J Lab Clin Med 2005; 145: 98104.
  • 10
    Endoh T, Tsuji N, Asanuma K, Yagihashi A, Watanabe N. Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription. Exp Cell Res 2005; 305: 30011.
  • 11
    Cassandra DB, Thomas RY, Patricia ML, Catherine AR. Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA 1997; 94: 1367782.
  • 12
    Greider CW. Telomere length regulation. Annu Rev Biochem 1996; 65: 33765.
  • 13
    Cong Y, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev 2002; 66: 40725.
  • 14
    Sikand K, Kaul D, Vaima N. Receptor Ck-dependent signaling regulates hTERT gene transcription. BMC Cell Biol 2006; 7: 2.
  • 15
    Blasco MA, Rizen M, Greider CW, Hanahan D. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. NatGenet 1996; 12: 2004.
  • 16
    Janknecht R. On the road to immortality: hTERT upregulation in cancer cells. FEBS Lett 2004; 564: 913.
  • 17
    Yin L, Hubbard AK, Giardina C. NF-κB regulates transcription of the mouse telomerase catalytic subunit. J Biol Chem 2000; 275: 36 6715.
  • 18
    Sinha-Datta U, Horikawa I, Michishita E, Datta A, Sigler-Nicot JC, Brown M, et al. Transcriptional activation of hTERT through the NF-κB pathway in HTLV-I-transformed cells. Blood 2004; 104: 252331.
  • 19
    Mandal M, Kumar R. Bcl-2 modulates telomerase activity. J Biol Chem 1997; 272: 141837.
  • 20
    Delorme B, Chateauvieux S, Charbord P. The concept of mesenchymal stem cells. Regen Med 2006; 1: 497509.
  • 21
    Tutter AV, Baltus GA, Kadam S. Embryonic stem cells: a great hope for a new era of medicine. Curr Opin Drug Discov Devel 2006; 9: 16975.
  • 22
    Zhang X, Xu Z, Ye L, Dong N, Zhao C, Cai B, et al. Isolation and identification of mesenchymal stem cells derived from human fetal bone marrow. Acta Scientiarum Naturalium Universitatis Nankaiensis 2006; 39: 10710. Chinese.
  • 23
    Autieri MV, Yue TL, Ferstein GZ, Ohlstein E. Antisense oligonucleotides to the p65 subunit of NF-κB inhibit human vascular smooth muscle cell adherence and proliferation and prevent neointima formation in rat carotid arteries. Biochem Biophys Res Commun 1995; 213: 82736.
  • 24
    Klapper W, Singh KK, Heidorn K, Parwaresch R, Krupp G. Regulation of telomerase activity in quiescent immortalized human cells. Biochim Biophys Acta 1998; 1442: 1206.
  • 25
    Broccoli D, Young JW, De Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995; 92: 908286.
  • 26
    Hiyama E, Hiyama K, Yokoyama T, Shay JW. Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia 2001; 3: 1726.
  • 27
    Zou L, Zhang P, Luo C, Tu Z. Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase transcription and telomerase activity. Urology 2006; 67: 133540.
  • 28
    Weng NP, Levine BL, June CH, Hodes RJ. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996; 183: 24719.
  • 29
    Ramirez RD, Wright WE, Shay JW, Taylor RS. Telomerase activity concentrates in the mitotically active segments of human hair follicles. J Invest Dermatol 1997; 108: 1137.
  • 30
    Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279: 34952.
  • 31
    Zhang PH, Zou L, Tu ZG. RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity. J Surg Res 2006; 131: 1439.
  • 32
    Massard C, Zermati Y, Pauleau AL, Larochette N, Metivier D, Sabatier L, et al. hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway. Oncogene 2006; 25: 450514.